Login
Users of this system, can login to view this document.
Enter the following information to request a copy of the document from the responsible person.
Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report